Key facts
- Smith-Byrne told MPs he did not find it plausible that known risk factors fully explain the rise.
- Hallmark mutations caused by colibactin were three times more common in tumors from people under 40 than in those over 70, per last year's research.
- Prof Elio Riboli told the committee colibactin is essentially found in people born after 1960.
- Prof Helen Coleman called colibactin the first new clue in quite some time but said its role is still under investigation.
- Riboli said about 60% of cancers occurring now could be prevented by applying known measures.
Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among people under 50, MPs on the Commons science and technology committee heard on November 18, 2026.
Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the committee that known risk factors for colorectal cancer, such as obesity, smoking and alcohol, can explain only about half of the cases doctors diagnose. He said he did not find it plausible that the rise in early onset bowel cancer could be entirely explained by risk factors researchers were already aware of. "That's probably the leading explanation at the moment," Smith-Byrne said of colibactin. He is himself a survivor of early onset rectal cancer.
In 2025 scientists identified a toxin called colibactin, produced by some variants of E coli bacteria in the gut, as a potential driver of early onset colorectal cancer. Hallmark mutations caused by the toxin were three times more common in tumors from people under 40 than in those from people over 70. More work is needed to understand whether colibactin actually drives bowel cancer, but it is a question scientists are now actively pursuing.
Prof Mike Stratton at the Sanger Institute, who was not at the hearing, has said colibactin causes mutations in some children but not others, with evidence of mutations appearing as early as infancy. By the age of 10, affected children can have a similar mutational burden to a 50-year-old, his work showed. Smith-Byrne said that if the toxin is causing mutations at a sensitive period earlier in life, it can give a person's colon or rectum a head start on its journey toward becoming cancerous.
Prof Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee: "This colibactin is essentially found in people born after 1960. Something has happened in the E coli bacteria." He said scientists need to uncover the unknown drivers of different cancers while people should minimize risks that are already clear. In the UK and US, drinking and smoking are both falling, but obesity is rising and physical activity is in decline. "The quick win could come from applying what we know," Riboli said. "We could prevent about 60% of the cancers occurring now, but we are not applying in society what we know."
Prof Helen Coleman, a cancer epidemiologist at Queen's University Belfast, told MPs that colibactin was "the first new clue that we've had in quite some time," but that its potential role in bowel cancer was still under investigation. She said that even though the adults being diagnosed are between 18 and 49, the exposures are quite likely to be very early in life, possibly even in the prenatal period, which makes the question difficult to study.
Bowel cancer is the third most common cancer in the world, accounting for about one in 10 of all cases. The disease is still far more common in the over-50s, but global figures suggest diagnoses are rising steeply in younger people.